The Life Sciences Today podcast by Healthcare IT Today brings you the most practical Life Sciences and pharma IT information. Focused on topics such as drug R&D, real world data (RWD), and clinical AI, we'll be covering a wide spectrum of technology in the pharma and life sciences space.
All content for Life Sciences Today is the property of Danny Lieberman and John Lynn and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Life Sciences Today podcast by Healthcare IT Today brings you the most practical Life Sciences and pharma IT information. Focused on topics such as drug R&D, real world data (RWD), and clinical AI, we'll be covering a wide spectrum of technology in the pharma and life sciences space.
Drug Development with Certara - Life Sciences Today Podcast Episode 30
Life Sciences Today
3 weeks ago
Drug Development with Certara - Life Sciences Today Podcast Episode 30
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Rajesh Krishna, Senior Distinguished Scientist at Certara and a recognized leader in drug development. With 25+ years of experience, he’s shaped model-informed strategies for biologics, vaccines, and small molecules, and is consistently ranked among the top 2% of influential scientists.
Drug development is too slow and expensive. Certara helps companies design better trials, predict outcomes, and reduce risk using modeling, simulation, and AI. The goal is straightforward: make it faster and more efficient to bring safe and effective drugs to patients.
For more great episodes of our Life Sciences Today Podcast, check out: https://www.healthcareittoday.com/category/life-sciences-today-podcasts/
Life Sciences Today
The Life Sciences Today podcast by Healthcare IT Today brings you the most practical Life Sciences and pharma IT information. Focused on topics such as drug R&D, real world data (RWD), and clinical AI, we'll be covering a wide spectrum of technology in the pharma and life sciences space.
